about
Blood glucose control in patients with severe sepsis and septic shockReducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.Early propranolol treatment induces lung heme-oxygenase-1, attenuates metabolic dysfunction, and improves survival following experimental sepsis.Should β-blockers be used in septic shock?Extent and magnitude of catecholamine surge in pediatric burned patients.Pre-existing atrial fibrillation and risk of arterial thromboembolism and death following pneumonia: a population-based cohort studyIncreased poly(ADP-ribosyl)ation in skeletal muscle tissue of pediatric patients with severe burn injury: prevention by propranolol treatment.Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study.Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.Bench-to-bedside review: Beta-adrenergic modulation in sepsis.Is propranolol of benefit in pediatric burn patients?Regulatory effect and mechanisms of carbon monoxide-releasing molecule II on hepatic energy metabolism in septic mice.Update on the critical care management of severe burns.β-Blockade use for Traumatic Injuries and Immunomodulation: A Review of Proposed Mechanisms and Clinical Evidence.Metabolism, Metabolomics, and Nutritional Support of Patients with Sepsis.β-Blockers in sepsis: protocol for a systematic review and meta-analysis of randomised control trials.The immune system's role in sepsis progression, resolution, and long-term outcome.Curcumin suppresses inflammatory cytokines and heat shock protein 70 release and improves metabolic parameters during experimental sepsis.Diabetes and Sepsis: Risk, Recurrence, and Ruination.A Potential Mechanism for Immune Suppression by Beta-Adrenergic Receptor Stimulation following Traumatic Injury.Beta-1 blocker improves survival of septic rats through preservation of gut barrier function.The Safety and Efficacy of Propranolol in Reducing the Hypermetabolic Response in the Pediatric Burn Population
P2860
Q22305498-9648A06D-54F0-49CC-BEE5-C952AE008B15Q30318384-B477AC71-3FE4-4AE9-A023-B3CB08CB9260Q33752604-DED1821F-E7CB-4666-8EE0-D7E183C29D88Q33753515-DED9BF3B-0837-48A1-A47D-D5A6EA7B6F24Q33807436-3CA69A65-A52B-4C54-8C11-2C42B056BCF9Q34573036-20009395-4B35-45F9-BCE0-8DAAA5F28D45Q35050684-33826CDD-EC47-4B17-8520-E7CDDD0ED065Q35559410-5D1CA96A-9ADC-46C9-986A-3C9B7AF11886Q35795306-72272117-4A63-4505-9A5F-88BFE5DB85A3Q37623067-DFD88E04-2F18-40D6-B7E3-31C697D4605AQ37640359-B1244346-AB5B-40B8-9CA0-CD0670006946Q37660699-048D9640-155E-45C1-8B6B-76207926AE05Q37901974-83C280CC-06CB-4B06-8C65-77BEECC390FEQ38832894-3160DB14-DC15-4B43-ADB7-7E7B645C65A3Q38845332-8CDC6C7A-9045-4151-8C87-66C6BE56C1A0Q38849114-891EC888-15D4-44FD-8761-CB4FC68005EBQ38991057-8FC7B432-2112-4C91-8336-CDBF917E77DBQ40420072-54551869-B2E8-4D4F-9E30-CB6430E8BC20Q47102661-CF998DA9-79A8-4682-B8AC-61ACB094EA1CQ49893245-952570CB-FB19-4F39-A21A-29D67845A93DQ51014969-F3510BC1-071D-498C-8299-96AD58DF6B78Q57797740-29FB0F08-616F-420E-9234-789D74E57AB7
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Metabolism modulators in sepsis: propranolol.
@en
type
label
Metabolism modulators in sepsis: propranolol.
@en
prefLabel
Metabolism modulators in sepsis: propranolol.
@en
P2093
P1476
Metabolism modulators in sepsis: propranolol.
@en
P2093
David N Herndon
Marc G Jeschke
William B Norbury
P304
P356
10.1097/01.CCM.0000278599.30298.80
P407
P433
P577
2007-09-01T00:00:00Z